Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-01-14

AUTHORS

Shinsuke Hamada, Akio Horiguchi, Kenji Kuroda, Keiichi Ito, Tomohiko Asano, Kosuke Miyai, Keiichi Iwaya

ABSTRACT

BackgroundFatty acid synthase (FAS) is highly expressed in various types of cancer, and elevated expression of FAS has been suggested to be a predictor of tumor aggressiveness and poor prognosis. We examined whether FAS expression in prostate biopsy cores could predict the pathological characteristics of radical prostatectomy (RP) specimens.MethodsParaffin-embedded prostate biopsy cores, obtained from 102 patients who subsequently underwent RP, were immunostained with polyclonal anti-FAS antibody. The staining intensity was categorized into non-staining, weak, moderate, and strong. Tumors with moderate or strong immunostaining were considered to show high FAS expression, and other tumors were considered to show low FAS expression. The relation between the FAS expression status in biopsy cores and pathological parameters in RP specimens was analyzed.ResultsThe FAS expression in the biopsy cores of 64 of the 102 tumors (63%) was high, whereas it was low in the biopsy cores of the other 38 tumors (37%). High FAS expression was significantly associated with Gleason Score (GS) ≥ 7 in RP specimens (p< 0.0001). In multivariable logistic regression analyses, GS ≥7 in biopsy cores (p <0.0001), higher preoperative PSA (p = 0.0194), and high FAS expression (p = 0.0004) were independent predictors of GS ≥ 7 in the RP specimen.ConclusionsIncreased FAS expression in prostate biopsy cores could be a novel parameter for predicting higher GS in RP specimens. The treatment strategy for patients with high FAS expression in prostate biopsy cores should be carefully determined. More... »

PAGES

3

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1472-6890-14-3

DOI

http://dx.doi.org/10.1186/1472-6890-14-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037729078

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24422874


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamada", 
        "givenName": "Shinsuke", 
        "id": "sg:person.0646643160.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646643160.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horiguchi", 
        "givenName": "Akio", 
        "id": "sg:person.0616322445.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616322445.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuroda", 
        "givenName": "Kenji", 
        "id": "sg:person.01224662271.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224662271.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ito", 
        "givenName": "Keiichi", 
        "id": "sg:person.0742101353.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742101353.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asano", 
        "givenName": "Tomohiko", 
        "id": "sg:person.011653555242.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011653555242.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Basic Pathology, National Defense Medical College, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
            "Department of Basic Pathology, National Defense Medical College, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyai", 
        "givenName": "Kosuke", 
        "id": "sg:person.01307144321.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307144321.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Basic Pathology, National Defense Medical College, Tokorozawa-City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan", 
            "Department of Basic Pathology, National Defense Medical College, Tokorozawa-City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iwaya", 
        "givenName": "Keiichi", 
        "id": "sg:person.01043156710.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043156710.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1208555", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001146542", 
          "https://doi.org/10.1038/sj.onc.1208555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024304300", 
          "https://doi.org/10.1038/nrc2222"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-01-14", 
    "datePublishedReg": "2014-01-14", 
    "description": "BackgroundFatty acid synthase (FAS) is highly expressed in various types of cancer, and elevated expression of FAS has been suggested to be a predictor of tumor aggressiveness and poor prognosis. We examined whether FAS expression in prostate biopsy cores could predict the pathological characteristics of radical prostatectomy (RP) specimens.MethodsParaffin-embedded prostate biopsy cores, obtained from 102 patients who subsequently underwent RP, were immunostained with polyclonal anti-FAS antibody. The staining intensity was categorized into non-staining, weak, moderate, and strong. Tumors with moderate or strong immunostaining were considered to show high FAS expression, and other tumors were considered to show low FAS expression. The relation between the FAS expression status in biopsy cores and pathological parameters in RP specimens was analyzed.ResultsThe FAS expression in the biopsy cores of 64 of the 102 tumors (63%) was high, whereas it was low in the biopsy cores of the other 38 tumors (37%). High FAS expression was significantly associated with Gleason Score (GS) \u2265 7 in RP specimens (p< 0.0001). In multivariable logistic regression analyses, GS \u22657 in biopsy cores (p <0.0001), higher preoperative PSA (p\u2009=\u20090.0194), and high FAS expression (p\u2009=\u20090.0004) were independent predictors of GS \u2265 7 in the RP specimen.ConclusionsIncreased FAS expression in prostate biopsy cores could be a novel parameter for predicting higher GS in RP specimens. The treatment strategy for patients with high FAS expression in prostate biopsy cores should be carefully determined.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1472-6890-14-3", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6047086", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1028422", 
        "issn": [
          "1472-6890"
        ], 
        "name": "BMC Clinical Pathology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "prostate biopsy cores", 
      "high FAS expression", 
      "Gleason score", 
      "high Gleason score", 
      "biopsy cores", 
      "radical prostatectomy", 
      "FAS expression", 
      "RP specimens", 
      "multivariable logistic regression analysis", 
      "fatty acid synthase expression", 
      "higher preoperative PSA", 
      "radical prostatectomy specimen", 
      "logistic regression analysis", 
      "types of cancer", 
      "preoperative PSA", 
      "independent predictors", 
      "RP specimen", 
      "poor prognosis", 
      "pathological parameters", 
      "pathological characteristics", 
      "treatment strategies", 
      "prostatectomy specimen", 
      "synthase expression", 
      "tumor aggressiveness", 
      "anti-Fas antibody", 
      "expression status", 
      "tumors", 
      "elevated expression", 
      "patients", 
      "regression analysis", 
      "acid synthase", 
      "scores", 
      "predictors", 
      "expression", 
      "novel parameter", 
      "prognosis", 
      "prostatectomy", 
      "MethodsParaffin", 
      "cancer", 
      "PSA", 
      "antibodies", 
      "specimens", 
      "aggressiveness", 
      "FAS", 
      "status", 
      "synthase", 
      "specimen", 
      "strategies", 
      "types", 
      "analysis", 
      "characteristics", 
      "intensity", 
      "parameters", 
      "relation", 
      "core"
    ], 
    "name": "Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen", 
    "pagination": "3", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037729078"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1472-6890-14-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24422874"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1472-6890-14-3", 
      "https://app.dimensions.ai/details/publication/pub.1037729078"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_629.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1472-6890-14-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6890-14-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6890-14-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6890-14-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6890-14-3'


 

This table displays all metadata directly associated to this object as RDF triples.

169 TRIPLES      21 PREDICATES      82 URIs      72 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1472-6890-14-3 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N4ea1565f506a406c80607805d9db8492
4 schema:citation sg:pub.10.1038/nrc2222
5 sg:pub.10.1038/sj.onc.1208555
6 schema:datePublished 2014-01-14
7 schema:datePublishedReg 2014-01-14
8 schema:description BackgroundFatty acid synthase (FAS) is highly expressed in various types of cancer, and elevated expression of FAS has been suggested to be a predictor of tumor aggressiveness and poor prognosis. We examined whether FAS expression in prostate biopsy cores could predict the pathological characteristics of radical prostatectomy (RP) specimens.MethodsParaffin-embedded prostate biopsy cores, obtained from 102 patients who subsequently underwent RP, were immunostained with polyclonal anti-FAS antibody. The staining intensity was categorized into non-staining, weak, moderate, and strong. Tumors with moderate or strong immunostaining were considered to show high FAS expression, and other tumors were considered to show low FAS expression. The relation between the FAS expression status in biopsy cores and pathological parameters in RP specimens was analyzed.ResultsThe FAS expression in the biopsy cores of 64 of the 102 tumors (63%) was high, whereas it was low in the biopsy cores of the other 38 tumors (37%). High FAS expression was significantly associated with Gleason Score (GS) ≥ 7 in RP specimens (p< 0.0001). In multivariable logistic regression analyses, GS ≥7 in biopsy cores (p <0.0001), higher preoperative PSA (p = 0.0194), and high FAS expression (p = 0.0004) were independent predictors of GS ≥ 7 in the RP specimen.ConclusionsIncreased FAS expression in prostate biopsy cores could be a novel parameter for predicting higher GS in RP specimens. The treatment strategy for patients with high FAS expression in prostate biopsy cores should be carefully determined.
9 schema:genre article
10 schema:isAccessibleForFree true
11 schema:isPartOf Nb8a5dc002b7b444083bf106f74f7fcbb
12 Nc46935229e424fac9f8e1c33bb5e287b
13 sg:journal.1028422
14 schema:keywords FAS
15 FAS expression
16 Gleason score
17 MethodsParaffin
18 PSA
19 RP specimen
20 RP specimens
21 acid synthase
22 aggressiveness
23 analysis
24 anti-Fas antibody
25 antibodies
26 biopsy cores
27 cancer
28 characteristics
29 core
30 elevated expression
31 expression
32 expression status
33 fatty acid synthase expression
34 high FAS expression
35 high Gleason score
36 higher preoperative PSA
37 independent predictors
38 intensity
39 logistic regression analysis
40 multivariable logistic regression analysis
41 novel parameter
42 parameters
43 pathological characteristics
44 pathological parameters
45 patients
46 poor prognosis
47 predictors
48 preoperative PSA
49 prognosis
50 prostate biopsy cores
51 prostatectomy
52 prostatectomy specimen
53 radical prostatectomy
54 radical prostatectomy specimen
55 regression analysis
56 relation
57 scores
58 specimen
59 specimens
60 status
61 strategies
62 synthase
63 synthase expression
64 treatment strategies
65 tumor aggressiveness
66 tumors
67 types
68 types of cancer
69 schema:name Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen
70 schema:pagination 3
71 schema:productId N36f3c366e836439b91ed589039913164
72 N4e782eb2fd20404db0a97062d9ce35b2
73 Nead8f894ccc24322bc9be0f601995f2e
74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037729078
75 https://doi.org/10.1186/1472-6890-14-3
76 schema:sdDatePublished 2022-12-01T06:32
77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
78 schema:sdPublisher N76956d7874e04cbbab52cb47ad0cb80d
79 schema:url https://doi.org/10.1186/1472-6890-14-3
80 sgo:license sg:explorer/license/
81 sgo:sdDataset articles
82 rdf:type schema:ScholarlyArticle
83 N238cd98e26a24a69816cf0a1d87ba6c3 rdf:first sg:person.0742101353.31
84 rdf:rest N4db2eb37ed3c4c45888759a9d7a24712
85 N2ae14a03c1d5464db5cb91aed67035a5 rdf:first sg:person.01224662271.36
86 rdf:rest N238cd98e26a24a69816cf0a1d87ba6c3
87 N36f3c366e836439b91ed589039913164 schema:name doi
88 schema:value 10.1186/1472-6890-14-3
89 rdf:type schema:PropertyValue
90 N4db2eb37ed3c4c45888759a9d7a24712 rdf:first sg:person.011653555242.33
91 rdf:rest N99a9d5fa92464bf98e2c10ad36f32d92
92 N4e782eb2fd20404db0a97062d9ce35b2 schema:name pubmed_id
93 schema:value 24422874
94 rdf:type schema:PropertyValue
95 N4ea1565f506a406c80607805d9db8492 rdf:first sg:person.0646643160.50
96 rdf:rest N7fdcc2cfdf184fc9947576defa55ad34
97 N76956d7874e04cbbab52cb47ad0cb80d schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 N7fdcc2cfdf184fc9947576defa55ad34 rdf:first sg:person.0616322445.22
100 rdf:rest N2ae14a03c1d5464db5cb91aed67035a5
101 N99a9d5fa92464bf98e2c10ad36f32d92 rdf:first sg:person.01307144321.06
102 rdf:rest Nc0d0158ec5094b80a1fc1297ab6f5aa8
103 Nb8a5dc002b7b444083bf106f74f7fcbb schema:volumeNumber 14
104 rdf:type schema:PublicationVolume
105 Nc0d0158ec5094b80a1fc1297ab6f5aa8 rdf:first sg:person.01043156710.91
106 rdf:rest rdf:nil
107 Nc46935229e424fac9f8e1c33bb5e287b schema:issueNumber 1
108 rdf:type schema:PublicationIssue
109 Nead8f894ccc24322bc9be0f601995f2e schema:name dimensions_id
110 schema:value pub.1037729078
111 rdf:type schema:PropertyValue
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
116 schema:name Oncology and Carcinogenesis
117 rdf:type schema:DefinedTerm
118 sg:grant.6047086 http://pending.schema.org/fundedItem sg:pub.10.1186/1472-6890-14-3
119 rdf:type schema:MonetaryGrant
120 sg:journal.1028422 schema:issn 1472-6890
121 schema:name BMC Clinical Pathology
122 schema:publisher Springer Nature
123 rdf:type schema:Periodical
124 sg:person.01043156710.91 schema:affiliation grid-institutes:grid.416614.0
125 schema:familyName Iwaya
126 schema:givenName Keiichi
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043156710.91
128 rdf:type schema:Person
129 sg:person.011653555242.33 schema:affiliation grid-institutes:grid.416614.0
130 schema:familyName Asano
131 schema:givenName Tomohiko
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011653555242.33
133 rdf:type schema:Person
134 sg:person.01224662271.36 schema:affiliation grid-institutes:grid.416614.0
135 schema:familyName Kuroda
136 schema:givenName Kenji
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224662271.36
138 rdf:type schema:Person
139 sg:person.01307144321.06 schema:affiliation grid-institutes:grid.416614.0
140 schema:familyName Miyai
141 schema:givenName Kosuke
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307144321.06
143 rdf:type schema:Person
144 sg:person.0616322445.22 schema:affiliation grid-institutes:grid.416614.0
145 schema:familyName Horiguchi
146 schema:givenName Akio
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616322445.22
148 rdf:type schema:Person
149 sg:person.0646643160.50 schema:affiliation grid-institutes:grid.416614.0
150 schema:familyName Hamada
151 schema:givenName Shinsuke
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646643160.50
153 rdf:type schema:Person
154 sg:person.0742101353.31 schema:affiliation grid-institutes:grid.416614.0
155 schema:familyName Ito
156 schema:givenName Keiichi
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742101353.31
158 rdf:type schema:Person
159 sg:pub.10.1038/nrc2222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024304300
160 https://doi.org/10.1038/nrc2222
161 rdf:type schema:CreativeWork
162 sg:pub.10.1038/sj.onc.1208555 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001146542
163 https://doi.org/10.1038/sj.onc.1208555
164 rdf:type schema:CreativeWork
165 grid-institutes:grid.416614.0 schema:alternateName Department of Basic Pathology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
166 Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan
167 schema:name Department of Basic Pathology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
168 Department of Urology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa-City, Saitama, Japan
169 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...